Concepedia

Alexandra Dos Santos Zimmer

AD

Statistics

Publications

2

Citations

64

H-Index

2

Active since

2016

Affiliations

National Cancer Institute(Current)

Alexandra Dos Santos Zimmer is an author at National Cancer Institute specializing in pd-l1 blockade, medical oncology, and medicine.

Publications per year

2016–2018

2

Publications

2

A phase II study of durvalumab, a PD-L1 inhibitor and olaparib in recurrent ovarian cancer (OvCa)

J.-M. Lee, Christina M. Annunziata, Nicole Houston et al. · Annals of Oncology · 2018 · 34 citations · Full text

, , +16

Phase I study of the PD-L1 inhibitor, durvalumab (MEDI4736; D) in combination with a PARP inhibitor, olaparib (O) or a VEGFR inhibitor, cediranib (C) in women's cancers (NCT02484404).

Jung‐Min Lee, Alexandra Dos Santos Zimmer, Stan Lipkowitz et al. · Journal of Clinical Oncology · 2016 · 30 citations

, , +17

1–2 of 2